|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
52527675
在线人数 :
1257
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
显示项目 342636-342645 / 2348570 (共234857页)
<< < 34259 34260 34261 34262 34263 34264 34265 34266 34267 34268 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T05:10:36Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SZU-MIN HSIEH |
| 臺大學術典藏 |
2018-09-10T05:14:27Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SUNG-CHING PAN |
| 臺大學術典藏 |
2018-09-10T05:14:32Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T02:30:20Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Sung-Ching Pan;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C.; SUNG-CHING PAN; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Pan S.-C.;Hsieh S.-M.;Chien-Ching Hung;Huang P.-F.;Chen M.-Y.;Chang S.-C.; Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Huang P.-F.; Chen M.-Y.; SZU-MIN HSIEH; Hung C.-C.; Pan S.-C.; Pan S.-C.;Szu-Min Hsieh;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:25Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Shan-Chwen Chang; Pan S.-C.; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-12-01T02:30:18Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 高雄醫學大學 |
2009 |
Dose reduction of parotid gland in treatment of Nasopharyngeal cancer with Helical Tomotherapy
|
連熙隆;方本詞;黃志仁;黃旼儀;白立柱;李惠娥 |
| 淡江大學 |
2008-07 |
Dose Self-efficacy Affect Career Commitment? Evidence from the Foodservice Industry
|
牛涵錚; Chen, Li-chan; Wang, Yau-de; Yang, chyan |
显示项目 342636-342645 / 2348570 (共234857页)
<< < 34259 34260 34261 34262 34263 34264 34265 34266 34267 34268 > >>
每页显示[10|25|50]项目
|
